The 2026 FSP Trends Report
Explore 2026 FSP trends to see how sponsors manage trial complexity, access talent and guide outsourcing decisions.
Drug developers are facing unprecedented drug development challenges, including increased complexity and costs, and extended trial timelines. These challenges, paired with pervasive uncertainty, a shifting regulatory landscape and patient recruitment and funding pressures, are driving biotech and biopharma sponsors to discover new and innovative ways to manage timelines and costs.
Our 2026 FSP Trends report shows that sponsors continue to leverage functional service provider (FSP) partnerships and mixed FSP/full-service outsourcing (FSO) models to manage complexity, access talent globally and enable on-time, on-budget delivery.
Our 2026 FSP Trends Report explores:
Complete the form to download the report